These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17941964)

  • 1. Social functioning as an outcome measure in schizophrenia studies.
    Burns T; Patrick D
    Acta Psychiatr Scand; 2007 Dec; 116(6):403-18. PubMed ID: 17941964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concepts of remission and recovery in schizophrenia.
    Leucht S; Lasser R
    Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study].
    Mayoral F; Montejo AL; Bousoño M; González-Torres MA; Olivares JM; Ros S; Sanjuán J; Escobar R; Lara N
    Actas Esp Psiquiatr; 2006; 34(1):7-15. PubMed ID: 16525900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia.
    Nasrallah H; Morosini P; Gagnon DD
    Psychiatry Res; 2008 Nov; 161(2):213-24. PubMed ID: 18848731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Positive and Negative Syndrome Scale short forms with global functioning and quality of life.
    Hochstrasser L; Borgwardt S; Lambert M; Schimmelmann BG; Lang UE; Stieglitz RD; Huber CG
    Acta Psychiatr Scand; 2016 Dec; 134(6):563-565. PubMed ID: 27869990
    [No Abstract]   [Full Text] [Related]  

  • 9. Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride.
    Saleem P; Olié JP; Loo H
    Int Clin Psychopharmacol; 2002 Jan; 17(1):1-8. PubMed ID: 11806403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?
    Brüne M; Abdel-Hamid M; Lehmkämper C; Sonntag C
    Schizophr Res; 2007 May; 92(1-3):151-9. PubMed ID: 17346931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
    Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
    Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel.
    Leifker FR; Patterson TL; Heaton RK; Harvey PD
    Schizophr Bull; 2011 Mar; 37(2):334-43. PubMed ID: 19525354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
    Iasevoli F; Giordano S; Balletta R; Latte G; Formato MV; Prinzivalli E; De Berardis D; Tomasetti C; de Bartolomeis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():34-48. PubMed ID: 26320028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new patient focused scale for measuring quality of life in schizophrenic patients: the Schizophrenia Quality of Life Scale (SOL)].
    Martin P; Caci H; Azorin JM; Daléry J; Hardy-Baylé MC; Etienne D; Gérard D; Peretti CS;
    Encephale; 2005; 31(5 Pt 1):559-66. PubMed ID: 16598960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment effectiveness in patients with schizophrenia as measured by the ASSESS battery - first longitudinal data.
    Ladea M; Barbu CM; Juckel G
    Psychiatr Danub; 2015 Dec; 27(4):364-70. PubMed ID: 26609648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective quality of life in patients with chronic schizophrenia: relationships between psychosocial and clinical characteristics.
    Kao YC; Liu YP; Chou MK; Cheng TH
    Compr Psychiatry; 2011; 52(2):171-80. PubMed ID: 21295224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.